NVCT
Nuvectis Pharma, Inc. · Healthcare
Chair, CEO and 10% owner Ron Bentsur bought $32K of Nuvectis Pharma, Inc.
Bought$31,990
$18.82Price
1,700Shares
What NVCT did for a copier
- $1,000 copied at Tue, May 17 open, $19.90
- $563
- S&P 500, same days
- −6.8%
Measured over 30 trading days, to the Jun 30 close.
Ron Bentsur's record
11 other buys with 3 months of prices since 2022: on average +65.3% against the S&P 500, and 8 of 11 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Fri, May 13. Filed Tue, May 17, 4:30 AM ET, before the open. Returns use the May 17 open and the Jun 30 close. Not investment advice.